- Home
- ADBE vs PFE Comparison
ADBE vs PFE Comparison
Compare ADBE & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADBE
- PFE
- Stock Information
- Founded
- ADBE 1982
- PFE 1849
- Country
- ADBE United States
- PFE United States
- Employees
- ADBE N/A
- PFE N/A
- Industry
- ADBE Computer Software: Prepackaged Software
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- ADBE Technology
- PFE Health Care
- Exchange
- ADBE Nasdaq
- PFE Nasdaq
- Market Cap
- ADBE 141.5B
- PFE 142.5B
- IPO Year
- ADBE 1986
- PFE N/A
- Fundamental
- Price
- ADBE $361.58
- PFE $25.86
- Analyst Decision
- ADBE Buy
- PFE Hold
- Analyst Count
- ADBE 22
- PFE 12
- Target Price
- ADBE $490.20
- PFE $29.36
- AVG Volume (30 Days)
- ADBE 3.7M
- PFE 43.9M
- Earning Date
- ADBE 09-11-2025
- PFE 08-05-2025
- Dividend Yield
- ADBE N/A
- PFE 6.69%
- EPS Growth
- ADBE 40.56
- PFE N/A
- EPS
- ADBE 15.63
- PFE 1.89
- Revenue
- ADBE $22,601,000,000.00
- PFE $63,833,000,000.00
- Revenue This Year
- ADBE $11.79
- PFE N/A
- Revenue Next Year
- ADBE $9.46
- PFE N/A
- P/E Ratio
- ADBE $22.61
- PFE $13.58
- Revenue Growth
- ADBE 10.63
- PFE 13.53
- 52 Week Low
- ADBE $330.04
- PFE $20.92
- 52 Week High
- ADBE $587.75
- PFE $30.43
- Technical
- Relative Strength Index (RSI)
- ADBE 48.53
- PFE 65.09
- Support Level
- ADBE $347.00
- PFE $24.47
- Resistance Level
- ADBE $364.24
- PFE $25.30
- Average True Range (ATR)
- ADBE 7.97
- PFE 0.43
- MACD
- ADBE 2.41
- PFE 0.15
- Stochastic Oscillator
- ADBE 73.39
- PFE 89.09
About ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.